{"canonical":"https://abierto.us/vendors/genentech-inc-f7f8gzxl7q93","key":"F7F8GZXL7Q93","name":"GENENTECH INC","uei":"F7F8GZXL7Q93","city":"SOUTH SAN FRANCISCO","state":"CA","awards":2,"obligated":"69390394.30","notices_won":9,"top_agency_name":"Office of Assistant Secretary for Preparedness and Response","top_naics":"541714","cage":"1HZ12","parent_name":"ROCHE HOLDING AG","also_known_as":[],"country":"USA","actions":14,"first_action":"2024-03-13","last_action":"2026-07-29","breakdowns":{"naics":[{"key":"541714","name":null,"awards":2,"obligated":"69390394.30"}],"places":[{"key":"MD","name":null,"awards":1,"obligated":"1085530.00"}],"agencies":[{"key":"7505","name":"Office of Assistant Secretary for Preparedness and Response","awards":1,"obligated":"68304864.30"},{"key":"7524","name":"Food and Drug Administration","awards":1,"obligated":"1085530.00"}],"award_types":[{"key":"DEFINITIVE CONTRACT","name":null,"awards":1,"obligated":"1085530.00"}],"competition":[{"key":"FULL AND OPEN COMPETITION","name":null,"awards":2,"obligated":"69390394.30"}],"product_service_codes":[{"key":"AN13","name":null,"awards":1,"obligated":"68304864.30"},{"key":"AJ11","name":null,"awards":1,"obligated":"1085530.00"}]},"awards_list":[{"award_key":"CONT_IDV_75A50118D00036_7505","permalink":"https://www.usaspending.gov/award/CONT_IDV_75A50118D00036_7505/","piid":"75A50118D00036","parent_piid":null,"award_type":null,"vendor_key":"F7F8GZXL7Q93","recipient_name":"GENENTECH INC","recipient_uei":"F7F8GZXL7Q93","recipient_cage":"1HZ12","recipient_city":"SOUTH SAN FRANCISCO","recipient_state":"CA","sub_name":"Office of Assistant Secretary for Preparedness and Response","office_name":"BARDA - ASPR / DAAPPO / BARDA DCMA","office_key":"o-75A501","first_action_date":"2024-03-13","last_action_date":"2026-07-29","actions":11,"obligated":"68304864.30","current_total_value":null,"potential_total_value":"636607100.30","naics":"541714","psc":"AN13","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":1,"description":"SUPPLEMENTAL FUNDING, REVISE OTTR, AND REVISE STATEMENT OF WORK.","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_75F40125C00069_7524_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75F40125C00069_7524_-NONE-_-NONE-/","piid":"75F40125C00069","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"F7F8GZXL7Q93","recipient_name":"GENENTECH INC","recipient_uei":"F7F8GZXL7Q93","recipient_cage":"1HZ12","recipient_city":"SOUTH SAN FRANCISCO","recipient_state":"CA","sub_name":"Food and Drug Administration","office_name":"FDA OFFICE OF ACQ GRANT SVCS","office_key":"o-75F401","first_action_date":"2025-09-11","last_action_date":"2026-06-11","actions":3,"obligated":"1085530.00","current_total_value":"1085530.00","potential_total_value":"1085530.00","naics":"541714","psc":"AJ11","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":1,"description":"THIS PROJECT FOCUSES ON ADDRESSING CRITICAL CHALLENGES IN THE DESIGN AND ANALYSIS OF HYBRID RANDOMIZED CONTROLLED TRIALS (RCTS) IN LONGITUDINAL SETTINGS. THE FIRST GOAL IS TO DEVELOP CAUSAL METHODOLOGIES FOR MANAGING DIVERSE MISSING DATA PATTERNS IN","method":null,"confidence":null,"evidence":null,"opportunity_key":"FDABAA2500123","opportunity_title":"FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science"}],"awards_total":2,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}